immunology
-
MedCity Influencers, BioPharma
Imagining an immune-driven future
The immune system is nature’s most finely-tuned diagnostic, so how will we use it to thwart disease and promote health?
-
Glenmark to spin off originator drugs business
The US-based subsidiary will bring together existing research and development and manufacturing businesses in the US, India and Switzerland.
-
Payer’s Place: Dawn Maroney
Dawn Maroney, President, Markets of Alignment Health and CEO of Alignment Health Plan, to discuss how they are using technology to provide better service and care to consumers.
-
BMS, Celgene tout synergies in $74B mega-deal, but Revlimid’s winter is coming
In a call to following news of the deal, executives pointed to near-term launch opportunities and pipelines, but some analysts expressed concern about the loss of patent protection for Revlimid and Opdivo.
-
Pandion raises $58M for its autoimmune platform inspired by the tumor microenvironment
Oncology has long been borrowing lessons from immunology. It may now be time to pay it back. Pandion Therapeutics is tapping into some immune evasion tools observed in cancer to better treat autoimmune and inflammatory disorders.
Promoted
Applying Remote Patient Monitoring to Surgery Prep and Recovery, Oncology and Women’s Health
Join us to learn about the latest trends in remote monitoring and how to extend its benefits beyond chronic conditions to more patients – all while using fewer staff resources.
Promoted
Payer’s Place: Dr. Anil Singh
Dr. Anil Singh shares his insights into the strategies employed by the organization to identify the most effective digital solutions for their members.
